BRINEURA Trademark

Trademark Overview

On Thursday, July 6, 2017, a trademark application was filed for BRINEURA with the United States Patent and Trademark Office. The USPTO has given the BRINEURA trademark a serial number of 87978085. The federal status of this trademark filing is REGISTERED as of Tuesday, October 2, 2018. This trademark is owned by Biomarin Pharmaceutical Inc.. The BRINEURA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Provide medical information related to the treatment of genetic diseases and disorders, the use of enzyme therapy
brineura

General Information

Serial Number87978085
Word MarkBRINEURA
Filing DateThursday, July 6, 2017
Status700 - REGISTERED
Status DateTuesday, October 2, 2018
Registration Number5577436
Registration DateTuesday, October 2, 2018
Mark Drawing3 - Illustration: Drawing or design which also includes word(s) / letter(s) / number(s)
Published for Opposition DateTuesday, November 7, 2017

Trademark Statements

Description of MarkThe mark consists of a light-green neural branch with two light-green bifurcations, each with a yellow-orange dot on the top; an upper-case letter of "B" and the lower-case letters of "rineura", all in light-green color.
Indication of Colors claimedThe color(s) light-green and yellow-orange is/are claimed as a feature of the mark.
Goods and ServicesProvide medical information related to the treatment of genetic diseases and disorders, the use of enzyme therapy

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateThursday, July 13, 2017
Primary Code044
First Use Anywhere DateFriday, December 1, 2017
First Use In Commerce DateFriday, December 1, 2017

Trademark Owner History

Party NameBiomarin Pharmaceutical Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressNovato, CA 94949
Party NameBiomarin Pharmaceutical Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressNovato, CA 94949

Trademark Events

Event DateEvent Description
Thursday, September 28, 2017ASSIGNED TO EXAMINER
Monday, July 10, 2017NEW APPLICATION ENTERED
Thursday, July 13, 2017NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, July 14, 2017NOTICE OF DESIGN SEARCH CODE E-MAILED
Thursday, September 28, 2017APPROVED FOR PUB - PRINCIPAL REGISTER
Wednesday, October 18, 2017NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Tuesday, November 7, 2017PUBLISHED FOR OPPOSITION
Tuesday, November 7, 2017OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, January 2, 2018NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, June 29, 2018TEAS STATEMENT OF USE RECEIVED
Friday, June 29, 2018DIVISIONAL REQUEST RECEIVED
Friday, June 29, 2018TEAS REQUEST TO DIVIDE RECEIVED
Friday, June 29, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 29, 2018TEAS CHANGE OF CORRESPONDENCE RECEIVED
Friday, June 29, 2018USE AMENDMENT FILED
Monday, July 16, 2018CASE ASSIGNED TO INTENT TO USE PARALEGAL
Monday, July 16, 2018DIVISIONAL PROCESSING COMPLETE
Monday, July 16, 2018STATEMENT OF USE PROCESSING COMPLETE
Monday, August 27, 2018ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 17, 2018NOTICE OF DESIGN SEARCH CODE E-MAILED
Wednesday, December 9, 2020TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
Wednesday, December 9, 2020ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
Wednesday, December 9, 2020TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS
Wednesday, December 9, 2020TEAS CHANGE OF CORRESPONDENCE RECEIVED
Monday, October 2, 2023COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED
Tuesday, July 30, 2024TEAS SECTION 8 & 15 RECEIVED
Tuesday, October 2, 2018REGISTERED-PRINCIPAL REGISTER
Tuesday, August 28, 2018NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED

Related Keywords

brineura diseases disorders enzyme therapy genetic treatment medical information related provide